Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stable Schizophrenia”

89 trials

Showing 20 of 89 results

Testing effectiveness (Phase 2)Study completedNCT01812642
What this trial is testing

A Pharmacokinetics Study to Evaluate Safety and Tolerability of JNJ-37822681 in Participants With Stable Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 33
Very early researchLooking for participantsNCT07344948
What this trial is testing

Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia

Who this might be right for
Healthy ParticipantsSchizophrenia Diagnosis
Neurosterix 73
Early research (Phase 1)Study completedNCT02320032
What this trial is testing

An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Who this might be right for
Schizophrenia
Alkermes, Inc. 140
Post-approval studies (Phase 4)Study completedNCT01010776
What this trial is testing

Evaluate Participants Satisfaction, Quality of Life and Effectiveness of Flexible-Dose of Paliperidone Extended Release (ER) in Participants With Schizophrenia, Previously Treated With Risperidone

Who this might be right for
Schizophrenia
Janssen-Cilag Farmaceutica Ltda. 223
Early research (Phase 1)Ended earlyNCT01568203
What this trial is testing

First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia

Who this might be right for
Schizophrenia
Amgen 50
Testing effectiveness (Phase 2)Study completedNCT03557931
What this trial is testing

Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication

Who this might be right for
Schizophrenia
Astellas Pharma Global Development, Inc. 233
Not applicableStudy completedNCT03389425
What this trial is testing

Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study

Who this might be right for
ObesityAbdominal Obesity
University of Calgary 9
Early research (Phase 1)Looking for participantsNCT07230652
What this trial is testing

MAD Study to Evaluate the Safety and Tolerability of LY03020

Who this might be right for
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd. 40
Early research (Phase 1)Study completedNCT00888693
What this trial is testing

A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With Schizophrenia

Who this might be right for
Schizophrenia
AbbVie 81
Testing effectiveness (Phase 2)Study completedNCT01450514
What this trial is testing

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

Who this might be right for
Chronic SchizophreniaSchizoaffective Disorder
PharmaNeuroBoost N.V. 7
Early research (Phase 1)Study completedNCT01556763
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderCentral Nervous System Diseases
FORUM Pharmaceuticals Inc 21
Early research (Phase 1)Study completedNCT01829048
What this trial is testing

Examine The Safety, Tolerability And Pharmacokinetics Of PF-02545920 In Psychiatrically Stable Subjects With Schizophrenia

Who this might be right for
Schizophrenia
Pfizer 37
Testing effectiveness (Phase 2)Study completedNCT03319953
What this trial is testing

A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

Who this might be right for
Stable Schizophrenia
Neurocrine Biosciences 23
Early research (Phase 1)Study completedNCT01879722
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants

Who this might be right for
Schizophrenia
Takeda 77
Testing effectiveness (Phase 2)Study completedNCT00825539
What this trial is testing

Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 68
Post-approval studies (Phase 4)Study completedNCT01663077
What this trial is testing

Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients

Who this might be right for
Schizophrenia
Tirat Carmel Mental Health Center 20
Not applicableEnded earlyNCT00506909
What this trial is testing

Oxytocin Add on Study for Stable Schizophrenic Patients

Who this might be right for
Schizophrenia
David Feifel 21
Testing effectiveness (Phase 2)Study completedNCT02205099
What this trial is testing

A Safety, Tolerability, PK and PD Study of Multiple Oral Doses of SKL15508 in Subjects With Stable Schizophrenia

Who this might be right for
Schizophrenia
SK Life Science, Inc. 39
Testing effectiveness (Phase 2)Study completedNCT00725075
What this trial is testing

Adjuvant Treatment With a Glycine Uptake Inhibitor in Participants With Negative Symptoms of Schizophrenia (P05695) (MK-8435-001)

Who this might be right for
Schizophrenia
Merck Sharp & Dohme LLC 215
Early research (Phase 1)Study completedNCT00463372
What this trial is testing

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Who this might be right for
SchizophreniaSchizo-affective Disorder
Pfizer 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation